|
1. 許瑞祥(1993)靈芝概論。萬年出版社。台中市。
2. Chihara G.Study on the antineoplastic activity and analysis of active fractions of Polyporaceae, Lentinus edodes and other basidiomycetes. Nippon Rinsho, 1969. 27(6): p. 1739-43.
3. Liou YF and Lin KH.Preparation of polysaccharides from Fomes
japonicus (Fr.) Sacc. -- screening for anti-tumor and cytotoxic
substances. Taiwan Yi Xue Hui Za Zhi, 1979. 78(6): p. 549-57.
4. Suzuki I, Itani T, Ohno N, Oikawa S, Sato K, Miyazaki T, Yadomae
T.Antitumor activity of a polysaccharide fraction extracted from
cultured fruiting bodies of Grifola frondosa. J Pharmacobiodyn,
1984. 7(7): p. 492-500.
5. Chen TW, Wong YK and Lee SS.In vitro cytotoxicity of Ganoderma
lucidum on oral cancer cells. Chung Hua i Hsueh Tsa Chih - Chinese
Medical Journal, 1991. 48(1): p. 54-8.
6. Zhu HS, Yang XL, Wang LB, Zhao DX and Chen L.Effects of extracts
from sporoderm-broken spores of Ganoderma lucidum on HeLa cells.
Cell Biol Toxicol, 2000. 16(3): p. 201-6.
7. Wang PH, Yang SF, Chen GD, Han CP, Chen SC, Lin LY, Ko JL. Human
nonmetastatic clone 23 type 1 gene suppresses migration of cervical
cancer cells and enhances the migration inhibition of fungal
immunomodulatory protein from Ganoderma tsugae. Reprod Sci, 2007.
14(5): p. 475-85.
8. Hu H, Ahn NS, Yang X, Lee YS, Kang KS.Ganoderma lucidum extract
48 induces cell cycle arrest and apoptosis in MCF-7 human breast cancer cell. Int J Cancer, 2002. 102(3): p. 250-3.
9. Sliva D, Sedlak M, Slivova V, Valachovicova T, Lloyd FP Jr, Ho NW.
Biologic activity of spores and dried powder from Ganoderma lucidum
for the inhibition of highly invasive human breast and prostate
cancer cells. J Altern Complement Med, 2003. 9(4): p. 491-7.
10. Jiang J, Slivova V, Valachovicova T, Harvey K, Sliva D.Ganoderma
lucidum inhibits proliferation and induces apoptosis in human
prostate cancer cells PC-3.Int J Oncol, 2004. 24(5): p. 1093-9.
11. Stanley G, Harvey K, Slivova V, Jiang J, Sliva D.Ganoderma lucidum suppresses angiogenesis through the inhibition of secretion of VEGF and TGF-beta1 from prostate cancer cells.Biochemical & Biophysical Research Communications, 2005. 330(1): p. 46-52.
12. Zaidman BZ, Wasser SP, Nevo E, Mahajna J.Androgen receptor
dependent and -independent mechanisms mediate Ganoderma lucidum
activities in LNCaP prostate cancer cells. Int J Oncol, 2007. 31(4):
p. 959-67.
13. Zaidman BZ, Wasser SP, Nevo E, Mahajna J.Coprinus comatus and
Ganoderma lucidum interfere with androgen receptor function in
LNCaP prostate cancer cells. Mol Biol Rep, 2008. 35(2): p. 107-17.
14. Lu QY, Jin YS, Zhang Q, Zhang Z, Heber D, Go VL, Li FP, Rao JY.
Ganoderma lucidum extracts inhibit growth and induce actin
polymerization in bladder cancer cells in vitro. Cancer Lett, 2004.
216(1): p. 9-20.
15. Xie JT, Wang CZ, Wicks S, Yin JJ, Kong J, Li J, Li YC, Yuan CS.
Ganoderma lucidum extract inhibits proliferation of SW 480 human
colorectal cancer cells. Exp Oncol, 2006. 28(1): p. 25-9.
16. Cao, Q.Z. and Z.B. Lin.Ganoderma lucidum polysaccharides peptide
inhibits the growth of vascular endothelial cell and the induction
of VEGF in human lung cancer cell. Life Sci, 2006. 78(13): p.
1457-63.
17. Tang W, Liu JW, Zhao WM, Wei DZ, Zhong JJ.Ganoderic acid T from
Ganoderma lucidum mycelia induces mitochondria mediated apoptosis
in lung cancer cells. Life Sci, 2006. 80(3): p. 205-11.
18. Liao CH, Hsiao YM, Sheu GT, Chang JT, Wang PH, Wu MF, Shieh GJ,
Hsu CP, Ko JL.Nuclear translocation of telomerase reverse
transcriptase and calcium signaling in repression of telomerase
activity in human lung cancer cells by fungal immunomodulatory
protein from Ganoderma tsugae. Biochemical Pharmacology, 2007.
74(10): p. 1541-54.
19. Nonaka Y, Ishibashi H, Nakai M, Shibata H, Kiso Y, Abe S.Effects
of the antlered form of Ganoderma lucidum on tumor growth and
metastasis in cyclophosphamide-treated mice. Biosci Biotechnol
Biochem, 2008. 72(6): p. 1399-408.
20. Gao Y, Tang W, Dai X, Gao H, Chen G, Ye J, Chan E, Koh HL, Li X,
Zhou S.Effects of water-soluble Ganoderma lucidum polysaccharides
on the immune functions of patients with advanced lung cancer. J
Med Food, 2005. 8(2): p. 159-68.
21. Gao Y, Zhou S, Jiang W, Huang M, Dai X.Effects of ganopoly (a
Ganoderma lucidum polysaccharide extract) on the immune functions
in advanced-stage cancer patients. Immunol Invest, 2003. 32(3): p.
201-15.
22. Yang HL.Ganoderic acid produced from submerged culture of Ganoderma lucidum induces cell cycle arrest and cytotoxicity in human
hepatoma cell line BEL7402. Biotechnology Letters, 2005. 27(12):
p. 835-8.
23. Müller CI, Kumagai T, O'Kelly J, Seeram NP, Heber D, Koeffler HP.
Ganoderma lucidum causes apoptosis in leukemia, lymphoma and
multiple myeloma cells. Leuk Res, 2006. 30(7): p. 841-8.
24. Stanley G, Harvey K, Slivova V, Jiang J, Sliva D.Ganoderma lucidum suppresses angiogenesis through the inhibition of secretion of VEGF and TGF-beta1 from prostate cancer cells. Biochem Biophys Res
Commun, 2005. 330(1): p. 46-52.
25. Chiu SW, Wang ZM, Leung TM, Moore D.Nutritional value of ganoderma extract and assessment of its genotoxicity and antigenotoxicity using comet assays of mouse lymphocytes. Food Chem Toxicol, 2000.38(2-3): p. 173-8.
26. Chen X, Hu ZP, Yang XX, Huang M, Gao Y, Tang W, Chan SY, Dai X,
Ye J, Ho PC, Duan W, Yang HY, Zhu YZ, Zhou SF.Monitoring of immune
responses to a herbal immuno-modulator in patients with advanced
colorectal cancer. Int Immunopharmacol, 2006. 6(3): p. 499-508.
27. Chan WK, Law HK, Lin ZB, Lau YL, Chan GC.Response of human dendritic cells to different immunomodulatory polysaccharides derived from mushroom and barley. Int Immunol, 2007. 19(7): p. 891-9.
28. Wang XM, Yang M, Guan SH, Liu RX, Xia JM, Bi KS, Guo DA.Quantitative determination of six major triterpenoids in Ganoderma lucidum and related species by high performance liquid chromatography. Journal of Pharmaceutical & Biomedical Analysis, 2006. 41(3): p. 838-44.
29. Kimura Y, Taniguchi M, Baba K.Antitumor and antimetastatic effects on liver of triterpenoid fractions of Ganoderma lucidum: mechanism of action and isolation of an active substance. Anticancer Res, 2002.22(6A): p. 3309-18.
30. Morigiwa A, Kitabatake K, Fujimoto Y, Ikekawa N.Angiotensin
converting enzyme-inhibitory triterpenes from Ganoderma lucidum.
Chem Pharm Bull (Tokyo), 1986. 34(7): p. 3025-8.
31. Lin LJ, Shiao MS.Separation of oxygenated triterpenoids from
Ganoderma lucidum by high-performance liquid chromatography. J
Chromatogr, 1987. 410(1): p. 195-200.
32. ATHERDEN LM.Studies with glycyrrhetic acid; inhibition of
metabolism of steroids in vitro. Biochem J, 1958. 69(1): p. 75-8.
33. Nishino H, Yoshioka K, Iwashima A, Takizawa H, Konishi S, Okamoto
H, Okabe H,Shibata S, Fujiki H, Sugimura T.Glycyrrhetic acid
inhibits tumor-promoting activity of teleocidin and
12-O-tetradecanoylphorbol-13-acetate in two-stage mouse skin
carcinogenesis. Jpn J Cancer Res, 1986. 77(1): p. 33-8.
34. Nishino H, Nishino A, Takayasu J, Hasegawa T, Iwashima A,
Hirabayashi K, Iwata S, Shibata S.Inhibition of the tumor
promoting action of 12-O-tetradecanoylphorbol-13-acetate by
some oleanane-type triterpenoid compounds. Cancer Research, 1988.
48(18): p. 5210-5.
35. Qiao Y, Zhang XM, Qiu MH.Two novel lanostane triterpenoids from
Ganoderma sinense. Molecules, 2007. 12(8): p. 2038-46.
36. Wang F, Liu JK.Highly oxygenated lanostane triterpenoids from the
fungus Ganoderma applanatum. Chem Pharm Bull (Tokyo), 2008. 56(7):
p. 1035-7.
37. Guan SH, Xia JM, Yang M, Wang XM, Liu X, Guo DA.Cytotoxic lanostanoid triterpenes from Ganoderma lucidum. J Asian Nat Prod Res, 2008.10(7-8): p. 705-10.
38. Lin SB, Li CH, Lee SS, Kan LS.Triterpene-enriched extracts from
Ganoderma lucidum inhibit growth of hepatoma cells via suppressing
protein kinase C, activating mitogen-activated protein kinases and
G2-phase cell cycle arrest. Life Sciences, 2003. 72(21): p.2381-90.
39. Burkhart DL, Viatour P, Ho VM, Sage J.GFP reporter mice for the
retinoblastoma-related cell cycle regulator p107. Cell Cycle, 2008.
7(16): p. 2544-52.
40. Yoshida T, Tanaka S, Mogi A, Shitara Y, Kuwano H.The clinical
significance of Cyclin B1 and Wee1 expression in non-small-cell
lung cancer. Ann Oncol, 2004. 15(2): p. 252-6.
41. Ratschiller D, Heighway J, Gugger M, Kappeler A, Pirnia F, Schmid
RA, Borner MM, Betticher DC.Cyclin D1 overexpression in bronchial
epithelia of patients with lung cancer is associated with smoking
and predicts survival. J Clin Oncol, 2003. 21(11): p. 2085-93.
42. Gan KH, Fann YF, Hsu SH, Kuo KW, Lin CN.Mediation of the cytotoxicity of lanostanoids and steroids of Ganoderma tsugae through apoptosis and cell cycle. J Nat Prod, 1998. 61(4): p. 485-7.
43. Hsu SC, Ou CC, Li JW, Chuang TC, Kuo HP, Liu JY, Chen CS, Lin SC,
Su CH, Kao MC. Ganoderma tsugae extracts inhibit colorectal cancer
cell growth via G(2)/M cell cycle arrest. J Ethnopharmacol, 2008.
120(3): p. 394-401.
44. Kim HS, Kacew S, Lee BM.In vitro chemopreventive effects of plant
polysaccharides (Aloe barbadensis miller, Lentinus edodes,
Ganoderma lucidum and Coriolus versicolor). Carcinogenesis, 1999.
20(8): p. 1637-40.
45. Hsu TL, Cheng SC, Yang WB, Chin SW, Chen BH, Huang MT, Hsieh SL,
Wong CH.Profiling carbohydrate-receptor interaction with recombinant innate immunity receptor-Fc fusion proteins. J Biol Chem, 2009. 284(50): p. 34479-89.
46. Lin YL, Lee SS, Hou SM, Chiang BL.Polysaccharide purified from
Ganoderma lucidum induces gene expression changes in human
dendritic cells and promotes T helper 1 immune response in BALB/c
mice. Mol Pharmacol, 2006. 70(2): p. 637-44.
47. Cheng KC, Huang HC, Chen JH, Hsu JW, Cheng HC, Ou CH, Yang WB, Chen ST, Wong CH, Juan HF.Ganoderma lucidum polysaccharides in human
monocytic leukemia cells: from gene expression to network
construction. BMC Genomics, 2007. 8: p. 411.
48. Wu TS, Shi LS, Kuo SC.Cytotoxicity of Ganoderma lucidum triterpenes.Journal of Natural Products, 2001. 64(8): p. 1121-2.
49. Huie CW, Di X.Chromatographic and electrophoretic methods for
Lingzhi pharmacologically active components. J Chromatogr B Analyt
Technol Biomed Life Sci, 2004. 812(1-2): p. 241-57.
50. el-Mekkawy S, Meselhy MR, Nakamura N, Tezuka Y, Hattori M, Kakiuchi N,Shimotohno K, Kawahata T, Otake T.Anti-HIV-1 and anti-
HIV-1-protease substances from Ganoderma lucidum. Phytochemistry,
1998. 49(6): p. 1651-7.
51. Min BS, Nakamura N, Miyashiro H, Bae KW, Hattori M.Triterpenes from the spores of Ganoderma lucidum and their inhibitory activity
against HIV-1 protease. Chem Pharm Bull (Tokyo), 1998. 46(10): p.
1607-12.
52. Kohda H, Tokumoto W, Sakamoto K, Fujii M, Hirai Y, Yamasaki K, Komoda Y,Nakamura H, Ishihara S, Uchida M.The biologically active
constituents of Ganoderma lucidum (Fr.) Karst. Histamine
release-inhibitory triterpenes. Chem Pharm Bull (Tokyo), 1985.
33(4): p. 1367-74.
53. Komoda Y, Shimizu M, Sonoda Y, Sato Y.Ganoderic acid and its
derivatives as cholesterol synthesis inhibitors. Chem Pharm Bull
(Tokyo), 1989. 37(2): p. 531-3.
54. Li CH, Chen PY, Chang UM, Kan LS, Fang WH, Tsai KS, Lin SB.Ganoderic acid X, a lanostanoid triterpene, inhibits topoisomerases and induces apoptosis of cancer cells. Life Sciences, 2005. 77(3): p.252-65.
55. Chang UM, Li CH, Lin LI, Huang CP, Kan LS, Lin SB.Ganoderiol F, a
ganoderma triterpene, induces senescence in hepatoma HepG2 cells.
Life Sci, 2006. 79(12): p. 1129-39.
56. Yang Y, Pan X, Lei W, Wang J, Song J.Transforming growth
factor-beta1 induces epithelial-to-mesenchymal transition and
apoptosis via a cell cycle-dependent mechanism. Oncogene, 2006.
25(55): p. 7235-44.
57. Sun GJ, Qian JJ, Meng XB, Song Y, Zhang F, Mei ZZ, Dong Y, Sun ZX.Mechanism of G2/M cell cycle arrest before apoptosis in leukemia
cell line HL-60 induced by proteasome inhibitor MG132. Ai Zheng,
2004. 23(10): p. 1144-8.
|